Section Arrow
Quote
ADPT.NASDAQ
- Adaptive Biotechnologies Corp
Quotes are at least 15-min delayed:2026/01/06 22:18 EST
Regular Hours
Last
 16.11
-0.06 (-0.37%)
Day High 
16.82 
Prev. Close
16.17 
1-M High
17.5 
Volume 
3.35M 
Bid
15
Ask
16.85
Day Low
15.78 
Open
16.17 
1-M Low
14.58 
Market Cap 
2.47B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 16.59 
20-SMA 16.07 
50-SMA 16.5 
52-W High 20.76 
52-W Low 5.975 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.52/-1.19
Enterprise Value
2.55B
Balance Sheet
Book Value Per Share
1.34
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
178.96M
Operating Revenue Per Share
1.24
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CYCNCyclerion Therapeutics1.95+0.57+41.30%-- 
ALMSAlumis Inc.16.23+7.92+95.31%0.33PE
MREOMereo BioPharma Group plc0.379-0.1016-21.14%-- 
SLSSELLAS Life Sciences Group4.1-0.9-18.00%-- 
RXRXRecursion Pharmaceuticals4.55+0.18+4.12%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product,clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is alsoavailable as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.